These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 8001648

  • 1. Effects of ABT-418, a novel cholinergic channel ligand, on place learning in septal-lesioned rats.
    Decker MW, Curzon P, Brioni JD, Arnerić SP.
    Eur J Pharmacol; 1994 Aug 11; 261(1-2):217-22. PubMed ID: 8001648
    [Abstract] [Full Text] [Related]

  • 2. ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys.
    Decker MW, Bannon AW, Curzon P, Gunther KL, Brioni JD, Holladay MW, Lin NH, Li Y, Daanen JF, Buccafusco JJ, Prendergast MA, Jackson WJ, Arneric SP.
    J Pharmacol Exp Ther; 1997 Oct 11; 283(1):247-58. PubMed ID: 9336330
    [Abstract] [Full Text] [Related]

  • 3. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
    Arneric SP, Sullivan JP, Briggs CA, Donnelly-Roberts D, Anderson DJ, Raszkiewicz JL, Hughes ML, Cadman ED, Adams P, Garvey DS.
    J Pharmacol Exp Ther; 1994 Jul 11; 270(1):310-8. PubMed ID: 7518514
    [Abstract] [Full Text] [Related]

  • 4. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
    Decker MW, Brioni JD, Sullivan JP, Buckley MJ, Radek RJ, Raszkiewicz JL, Kang CH, Kim DJ, Giardina WJ, Wasicak JT.
    J Pharmacol Exp Ther; 1994 Jul 11; 270(1):319-28. PubMed ID: 7913497
    [Abstract] [Full Text] [Related]

  • 5. Anxiolytic-like effects of the novel cholinergic channel activator ABT-418.
    Brioni JD, O'Neill AB, Kim DJ, Buckley MJ, Decker MW, Arneric SP.
    J Pharmacol Exp Ther; 1994 Oct 11; 271(1):353-61. PubMed ID: 7965735
    [Abstract] [Full Text] [Related]

  • 6. Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: a novel cholinergic channel activator for memory enhancement.
    Buccafusco JJ, Jackson WJ, Terry AV, Marsh KC, Decker MW, Arneric SP.
    Psychopharmacology (Berl); 1995 Aug 11; 120(3):256-66. PubMed ID: 8524972
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A comparative study of the effects of ABT-418 and methylphenidate on spatial memory in an animal model of ADHD.
    Guo T, Yang C, Guo L, Liu K.
    Neurosci Lett; 2012 Oct 18; 528(1):11-5. PubMed ID: 22985505
    [Abstract] [Full Text] [Related]

  • 10. Effects of nicotine on spatial memory deficits in rats with septal lesions.
    Decker MW, Majchrzak MJ, Anderson DJ.
    Brain Res; 1992 Feb 14; 572(1-2):281-5. PubMed ID: 1611524
    [Abstract] [Full Text] [Related]

  • 11. ABT-418: discriminative stimulus properties and effect on ventral tegmental cell activity.
    Brioni JD, Kim DJ, Brodie MS, Decker MW, Arneric SP.
    Psychopharmacology (Berl); 1995 Jun 14; 119(4):368-75. PubMed ID: 7480515
    [Abstract] [Full Text] [Related]

  • 12. SIB-1553A, (+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride, a subtype-selective ligand for nicotinic acetylcholine receptors with putative cognitive-enhancing properties: effects on working and reference memory performances in aged rodents and nonhuman primates.
    Bontempi B, Whelan KT, Risbrough VB, Rao TS, Buccafusco JJ, Lloyd GK, Menzaghi F.
    J Pharmacol Exp Ther; 2001 Oct 14; 299(1):297-306. PubMed ID: 11561092
    [Abstract] [Full Text] [Related]

  • 13. GABAergic septohippocampal neurons are not necessary for spatial memory.
    Pang KC, Nocera R, Secor AJ, Yoder RM.
    Hippocampus; 2001 Oct 14; 11(6):814-27. PubMed ID: 11811676
    [Abstract] [Full Text] [Related]

  • 14. Anticholinergic sensitivity in the aging rat septohippocampal system as assessed in a spatial memory task.
    Nilsson OG, Gage FH.
    Neurobiol Aging; 1993 Oct 14; 14(5):487-97. PubMed ID: 8247231
    [Abstract] [Full Text] [Related]

  • 15. Central nicotinic receptor agonists ABT-418, ABT-089, and (-)-nicotine reduce distractibility in adult monkeys.
    Prendergast MA, Jackson WJ, Terry AV, Decker MW, Arneric SP, Buccafusco JJ.
    Psychopharmacology (Berl); 1998 Mar 14; 136(1):50-8. PubMed ID: 9537682
    [Abstract] [Full Text] [Related]

  • 16. Galantamine-induced behavioral recovery after sublethal excitotoxic lesions to the rat medial septum.
    Mulder J, Harkany T, Czollner K, Cremers TI, Keijser JN, Nyakas C, Luiten PG.
    Behav Brain Res; 2005 Aug 30; 163(1):33-41. PubMed ID: 15951032
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Distinct profile of working memory errors following acute or chronic disruption of the cholinergic septohippocampal pathway.
    Stackman RW, Walsh TJ.
    Neurobiol Learn Mem; 1995 Nov 30; 64(3):226-36. PubMed ID: 8564376
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of sustained attention performance by the nicotinic acetylcholine receptor agonist ABT-418 in intact but not basal forebrain-lesioned rats.
    McGaughy J, Decker MW, Sarter M.
    Psychopharmacology (Berl); 1999 May 30; 144(2):175-82. PubMed ID: 10394999
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.